As I wrote in my last note on Structure: The most famous examples of GLP-1 agonist drugs are Novo Nordisk's (NVO) semaglutide - approved to treat Type 2 Diabetes ("T2D") under the brand name ...

Discover science-backed methods to address sagging skin, including home remedies and clinical treatment for those ...

The rise of these medications is causing many patients to experience what's now commonly known as 'Ozempic face,' a term coined by New York-based dermatologist Paul Jarrod Frank, MD that refers to the ...

A study from Cornell researchers could enable a quantum leap forward in identifying and deciphering cancer-driving genetic ...

Scientists have long struggled to target proteins that lack defined structure and are involved in cancer, neurodegenerative ...

Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many ...

Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

The latest version of Google DeepMind and Isomorphic Labs’ AlphaFold model can predict the structure and relationships not only of proteins, but “all of life’s molecules”, according to its ...

As evident, Hazlitt’s one lesson has vast applications. This essay now delves into its deployment on the Danish welfare state ...

Protein folding is the process by which proteins achieve their mature functional (native) tertiary structure, and often begins co-translationally. Protein folding requires chaperones and often ...